Month: <span>November 2020</span>

Home / 2020 / November
Breast cancer discovery could help stop disease’s deadly spread
Post

Breast cancer discovery could help stop disease’s deadly spread

UNIVERSITY OF VIRGINIA HEALTH SYSTEM IMAGE: UVA’S SANCHITA BHATNAGAR, PHD, FOUND THAT THE BREAST CANCER ONCOGENE TRIM37 NOT ONLY CAUSES TRIPLE NEGATIVE BREAST CANCER TO SPREAD BUT ALSO MAKES IT RESISTANT TO CHEMOTHERAPY. University of Virginia Cancer Center researchers have identified a gene responsible for the spread of triple-negative breast cancer to other parts of the body...

Post

Antimicrobial peptides with anticancer properties

COMPUSCRIPT LTD Announcing a new article publication for BIO Integration journal. In this article the authors Zhong, Cuiyu; Zhang, Lei; Huang, Jiandong; Huang, Songyin; Yao, Yandan from Sun Yat-sen University, Guangzhou, China; Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China and Shenzhen Institutes of Advanced Technology, Guangdong, China review antimicrobial peptides with anticancer properties. There is...

Post

Understanding lung infections in patients with cystic fibrosis

UNIVERSITY OF WARWICK Staphylococcus aureus (which includes MRSA) is the most prevalent organism isolated from the airways of children with cystic fibrosis (CF), and is treated using antibiotics, but its role in lung disease is poorly understood Using pig lungs from a butcher and synthetic mucus, researchers from the University of Warwick have shown that S. aureus preferentially colonises mucus,...

WHO Casts Doubts on Remdesivir’s Effectiveness Against COVID-19; Goes Against FDA’s Recommendations
Post

WHO Casts Doubts on Remdesivir’s Effectiveness Against COVID-19; Goes Against FDA’s Recommendations

The World Health Organization is now advising doctors from using Gilead Sciences’ Remdesivir as a treatment for the global pandemic virus, COVID-19, saying that there is no sufficient evidence that shows its effects. The world is hanging on to the recommendations of the experts from WHO but the United States’ FDA already listed it as...

Post

Three reasons why COVID-19 can cause silent hypoxia

BOSTON UNIVERSITY Scientists are still solving the many puzzling aspects of how the novel coronavirus attacks the lungs and other parts of the body. One of the biggest and most life-threatening mysteries is how the virus causes “silent hypoxia,” a condition when oxygen levels in the body are abnormally low, which can irreparably damage vital...

Anti-COVID-19 nasal spray ‘ready for use in humans’
Post

Anti-COVID-19 nasal spray ‘ready for use in humans’

by  University of Birmingham A nasal spray that can provide effective protection against the COVID-19 virus has been developed by researchers at the University of Birmingham, using materials already cleared for use in humans. A team in the university’s Healthcare Technologies Institute formulated the spray using compounds already widely approved by regulatory bodies in the UK,...

Stanford team creates cellular atlas of the human lung
Post

Stanford team creates cellular atlas of the human lung

by Bob Yirka , Medical Xpress A team of researchers from multiple departments at Stanford University has created a cellular atlas of the human lung that highlights the dozens of cell types that comprise parts of the lungs. In their paper published in the journal Nature, the researchers describe their work (mostly involving single-cell RNA sequencing)...

Fever, aches from Pfizer, Moderna jabs aren’t dangerous but may be intense for some
Post

Fever, aches from Pfizer, Moderna jabs aren’t dangerous but may be intense for some

A shingles vaccine created this reaction at the injection site. Some people who received Moderna’s new COVID-19 vaccine also had local redness, swelling, or pain. This summer, Luke Hutchison, a Massachusetts Institute of Technology–educated computational biologist, volunteered for a trial of Moderna’s COVID-19 vaccine. After he got the second injection, his arm immediately swelled up...

Drug eases recovery for those with severe alcohol withdrawal
Post

Drug eases recovery for those with severe alcohol withdrawal

by Bill Hathaway,  Yale University A drug once used to treat high blood pressure can help alcoholics with withdrawal symptoms reduce or eliminate their drinking, Yale University researchers report Nov. 19 in the American Journal of Psychiatry. In a double-blind study, researchers gave the drug prazosin or a placebo to 100 people entering outpatient treatment after being diagnosed...

Sharpening the Molecular Scissors: Advances in Gene-Editing Technology
Post

Sharpening the Molecular Scissors: Advances in Gene-Editing Technology

The ability to precisely modify human genes has been made possible by the development of tools such as mega nucleases, zinc finger nucleases, TALENs, and CRISPR/Cas. These now make it possible to generate targeted deletions, insertions, gene knock outs, and point variants; to modulate gene expression by targeting transcription factors or epigenetic machineries to DNA;...